Anny worked 28 years at MSD in clinical research and medical affairs, leading observational studies, early access programs, and academic partnerships. She helped launch the MSDAVENIR fund and served as VP of ariis. Now active with FIAC and Seintinelles, she also advises MSDAVENIR and INSERM Transfert.
Anny Tirel represents Seintinelles, a citizen community supporting cancer research, and chairs the FIAC Stakeholder Committee, which brings together patients, researchers, care centers, and public-private actors (INCa, HDH, ariis, France Biotech, major pharma companies).
